Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial

BACKGROUND: Patients with acute myocardial infarction are at greater risk for chronic heart failure and mortality. Currently, there is limited evidence supporting the beneficial effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in non-diabetic patients with reduced left...

Descripción completa

Detalles Bibliográficos
Autores principales: Khiali, Sajad, Taban-Sadeghi, Mohammadreza, Sarbakhsh, Parvin, Khezerlouy-Aghdam, Naser, Namdar, Hossein, Salehi, Rezvanieh, Rezagholizadeh, Afra, Entezari-Maleki, Taher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557181/
https://www.ncbi.nlm.nih.gov/pubmed/37803449
http://dx.doi.org/10.1186/s13063-023-07682-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557181/
https://www.ncbi.nlm.nih.gov/pubmed/37803449
http://dx.doi.org/10.1186/s13063-023-07682-6

Ejemplares similares